Liver regeneration study for patients with small future liver remnant
Part of Cancer, Digestive system clinical trials.
This trial tests techniques to help the liver grow before surgery in people who have a liver tumor and whose future liver remnant is too small. The goal is to make the liver big enough to safely remove the tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a liver tumor (benign or malignant)
- Your future liver remnant is considered too small (less than 20% to 40% of total liver volume) by your medical team
- You are able to give informed consent
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies different ways to place treatments inside the liver to control liver tumors when they can’t be removed with surgery or ablation. It may help certain people by improving how well the tumor is treated while keeping liver function safer.
This trial studies a way to help people who need liver surgery but have a very small remaining liver after the operation. It tests a special growth observation approach to see if it can safely increase the size of the future liver remnant.
This trial tests a new way to preserve donated livers before transplant, which may help people with severe liver disease get a transplant sooner. It may be an option for patients with certain cancers or urgent liver failure.
This trial tests a new imaging system to help surgeons plan liver removal operations. If you have a liver tumor that can be removed, this study may help improve surgical accuracy and outcomes.
This trial explores using smaller liver grafts in a partial transplant to treat portal hypertension, which may help patients avoid full transplant risks. It compares this approach to standard liver transplant.
This trial tests a new way to control blood flow during laparoscopic liver surgery. It compares two methods to see which is safer and more effective for patients with certain liver conditions.
Hear when a new Liver Cancer (Primary and Metastatic) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.